EXTON, PA -- (MARKET WIRE) -- November 28, 2006 -- Rheologics, Inc., a subsidiary of Rheologics Technologies, Inc. (PINKSHEETS: RTGI), (“Rheologics”), the leader in the study of blood viscosity and its relationship to cardiovascular disease, is pleased to announce that its Laboratory Services unit has launched its Whole Blood Viscosity (WBV) testing program for physicians.